Orion Pharma
Manufacturing · Finland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Orionintie 1a, Espoo, Uusimaa, 02101, Fi...Website
www.orionpharma.comRevenue
$1.2 BillionIndustry
About Orion Pharma
Orion Pharma Org Chart
Is Orion Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Orion Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Orion Pharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Orion Pharma has new funding data
Check if Orion Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Orion Pharma
Check out if Orion Pharma is spiking on competitors!
Product Launch: Get notified when Orion Pharma launches new products
Orion Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Orion Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Orion Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orion Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orion Pharma.
Orion Pharma Tech Stack
A closer look at the technologies used by Orion Pharma
Most Recent Scoops
Orion Pharma News & Media
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 1 June 2026 at 14.00 EESTOrion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EESTOrion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
ORION CORPORATION PRESS RELEASE 21 MAY 2026 at 10:30 EEST105,950 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 15 MAY 2026 at 9.00 EEST
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orion Pharma
Orion Corp is a company that operates in the Pharmaceuticals industry. It employs 1000to4999 people and has 1Gto5G of revenue. The company is headquartered in Espoo, Uusimaa, Finland.... Read More